Provenienza dei contatti di primo grado di Ulrich Wiesner
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
Elucida Oncology, Inc.
 Elucida Oncology, Inc. BiotechnologyHealth Technology Elucida Oncology, Inc. operates as a biotechnology company which focuses on clinical research and development. The company was founded by Isaac Blech, Michelle Bradbury, Ulrich Weisner, and Steven Larson in 2014 and is headquartered in Monmouth Junction, NJ.
12
| Holding Company | Biotechnology | 12 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Ulrich Wiesner tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
Wyeth Corp.
 Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Executive Officer President | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Carnegie Mellon University
 Carnegie Mellon University Other Consumer ServicesConsumer Services Carnegie Mellon University is an American school that operates as a college or university. It is located in Pittsburgh, Pennsylvania. | College/University | Masters Business Admin | |
UBS Americas, Inc.
 UBS Americas, Inc. Investment ManagersFinance UBS Americas, Inc. provides investment advice services. It offers wealth, asset management and investment banking services. The company was founded in 2000 and is headquartered in Stamford, CT. | Investment Managers | Chairman | |
| ON SEMICONDUCTOR CORPORATION | Semiconductors | Director/Board Member | |
UBS Securities LLC
 UBS Securities LLC Investment ManagersFinance UBS Securities LLC is an investment bank and registered broker/dealer headquartered in New York City. The firm was founded in 1998 as UBS Warburg LLC. They are a subsidiary of UBS Americas Holding LLC, ultimately held by UBS Group AG (SWX: UBSG, NYSE: UBS) in Switzerland. UBS Securities is a primary dealer in US Government securities and provides a full range of investment banking services which includes corporate finance, mergers and acquisitions, capital markets, trading and sales, fixed-income, equity research, private banking, underwriting and prime brokerage operations. The firm also provides advisory services and access to capital markets for corporate, institutional, intermediary and alternative asset management clients. | Investment Managers | Chief Executive Officer | |
| UBS | Investment Managers | Chief Executive Officer | |
| ATLANTIC POWER CORPORATION | Electric Utilities | Director/Board Member | |
Wyeth Pharmaceuticals LLC
 Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals LLC develops pharmaceutical, biotechnology and vaccine technologies. The company was registered on May 5, 2003 and is headquartered in Collegeville, PA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| PRECISION BIOSCIENCES, INC. | Biotechnology | Director/Board Member | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Elicio Therapeutics, Inc. (Old)
 Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Director/Board Member | |
| Boston University | College/University | Undergraduate Degree | |
Kaiser Permanente Washington Health Research Institute
 Kaiser Permanente Washington Health Research Institute Hospital/Nursing ManagementHealth Services Kaiser Permanente Washington Health Research Institute is a non profit organization that provides healthcare plans and services. It focuses on total health of its members and guided by personal physicians, specialists, and team of caregivers. Its expert and caring medical teams are empowered and supported by industry-leading technology advances and tools for health promotion, disease prevention, care delivery, and chronic disease management. The company was founded in 1983 and is headquartered in Seattle, WA. | Hospital/Nursing Management | Corporate Officer/Principal | |
| Rensselaer Polytechnic Institute | College/University | Masters Business Admin | |
| University of Delaware | College/University | Graduate Degree | |
| University of Michigan | College/University | Undergraduate Degree Doctorate Degree | |
University of Connecticut Health Center
 University of Connecticut Health Center Other Consumer ServicesConsumer Services University of Connecticut Health Center provides healthcare services. It is an organization, which composed of the school of medicine, John Dempsey hospital, the UConn medical group & health partners, and university dentists. It offers services for cardiovascular, cancer, behavioral, ambulatory, and neonatal intensive-care. The company was founded in 1961 and is headquartered in Farmington, CT. | College/University | Director/Board Member | |
| SCHRÖDINGER, INC. | Packaged Software | Director/Board Member | |
Nabriva Therapeutics GmbH
 Nabriva Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Nabriva Therapeutics GmbH is a clinical-stage biopharmaceutical company, which engages in the research and development of novel anti-infective agents to treat serious infections. It focuses on the pleuromutilin class of antibiotics. The company was founded by Rodger Novak in October 2005 and is headquartered in Vienna, Austria. | Pharmaceuticals: Major | Director of Finance/CFO | |
Olayan America Corp.
 Olayan America Corp. Investment ManagersFinance Olayan America Corp (Olayan America) is a private equity subsidiary of The Olayan Group founded in 1971. The firm is headquartered in New York. | Investment Managers | Director of Finance/CFO | |
| IBIO, INC. | Pharmaceuticals: Other | Director/Board Member | |
| SPENDSMART NETWORKS, INC. | Advertising/Marketing Services | Director/Board Member President | |
| INVESCO MUNICIPAL INCOME OPPORTUNITIES TRUST | Investment Trusts/Mutual Funds | Director/Board Member | |
| INVESCO VALUE MUNICIPAL INCOME TRUST | Investment Trusts/Mutual Funds | Director/Board Member | |
| INVESCO HIGH INCOME TRUST II | Investment Trusts/Mutual Funds | Director/Board Member | |
| INVESCO MUNICIPAL TRUST | Investment Trusts/Mutual Funds | Director/Board Member | |
| INVESCO TRUST FOR INVESTMENT GRADE MUNICIPALS | Investment Trusts/Mutual Funds | Director/Board Member | |
| INVESCO TRUST FOR INVESTMENT GRADE NEW YORK MUNICIPALS | Investment Trusts/Mutual Funds | Director/Board Member | |
| INVESCO MUNICIPAL OPPORTUNITY TRUST | Investment Trusts/Mutual Funds | Director/Board Member | |
| INVESCO BOND FUND | Investment Trusts/Mutual Funds | Director/Board Member | |
| INVESCO CALIFORNIA VALUE MUNICIPAL INCOME TRUST | Investment Trusts/Mutual Funds | Director/Board Member | |
| INVESCO ADVANTAGE MUNICIPAL INCOME TRUST II | Investment Trusts/Mutual Funds | Director/Board Member | |
Sapience Therapeutics, Inc.
 Sapience Therapeutics, Inc. BiotechnologyHealth Technology Sapience Therapeutics, Inc. focuses on advancing novel therapeutics for major unmet medical needs, particularly high mortality cancers. Its drug development program involves translating science into novel therapies, and initial goal is to develop a first-in-class treatment for glioblastoma multiforme, which is the most severe and deadly form of brain cancer. The company was founded by Barry Kappel and Isaac Blech in 2015 and is headquartered in Scarsdale, NY. | Biotechnology | Director/Board Member Founder | |
Nacuity Pharmaceuticals, Inc.
 Nacuity Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Nacuity Pharmaceuticals, Inc. develops and markets pharmaceutical products. The company is headquartered in Fort Worth, TX. | Pharmaceuticals: Major | Director/Board Member Founder | |
| NABRIVA THERAPEUTICS PLC | Pharmaceuticals: Major | Director of Finance/CFO | |
| INVESCO HIGH INCOME 2024 TARGET TERM FUND | Investment Trusts/Mutual Funds | Director/Board Member | |
| HARMONY BIOSCIENCES HOLDINGS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Harmony Biosciences LLC
 Harmony Biosciences LLC Pharmaceuticals: MajorHealth Technology Harmony Biosciences LLC operates as a biopharmaceutical company which develops therapies to help patients with unmet medical needs. It provides novel treatment options to patients with orphan and rare conditions, with an emphasis on central nervous system disorders. The company is headquartered in Plymouth Meeting, PA. | Pharmaceuticals: Major | Director/Board Member | |
Lipidio Pharmaceuticals, Inc.
 Lipidio Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lipidio Pharmaceuticals, Inc. develops and manufactures medicines. It focuses on developing drugs to treat diseases associated with excess body fat and its lead program, GDD3898, is being investigated for the treatment of nonalcoholic steatohepatitis (NASH) and Prader Willi syndrome (PWS), an orphan disease, and anti-psychotic drug induced weight gain (AIWG). The company was founded by Jay Edward Birnbaum and is headquartered San Diego, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Merck & Co. | Real Estate Development | Investor Relations Contact | |
Gennao Bio, Inc.
 Gennao Bio, Inc. Pharmaceuticals: MajorHealth Technology Gennao Bio, Inc. is a privately-held genetic medicines company that is developing first-in-class, non-viral, targeted nucleic acid therapeutics utilizing its proprietary gene monoclonal antibody (gmab) platform technology. The company is based in Pennington, NJ. The company's gmab technology uses a novel, cell-penetrating antibody to non-covalently bind to, and deliver therapeutic levels of a wide variety of nucleic acid payloads, to select cells. Gennao Bio is initially focusing on addressing significant unmet needs in oncology and rare monogenic skeletal muscle diseases. The company's non-viral delivery platform offers significant advantages over traditional gene delivery systems as it can deliver multiple types of nucleic acids, allows for repeat dosing and dose optimization, and can be easily and affordably manufactured. The company was founded in 2020 by Bruce Turner, Elias Quijano, Peter M. Glazer, Stephen P. Squinto. Christopher M. Duke has been the CEO of the company since 2021. | Pharmaceuticals: Major | Director/Board Member | |
| ARIDIS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| SYNERGY PHARMACEUTICALS INC | Pharmaceuticals: Major | Director of Finance/CFO | |
| ADHERA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member |
Statistiche
Distribuzione geografica
| Stati Uniti | 47 |
| Regno Unito | 2 |
| Svizzera | 2 |
| Austria | 2 |
| Irlanda | 2 |
Settori
| Health Technology | 21 |
| Miscellaneous | 13 |
| Consumer Services | 7 |
| Finance | 6 |
| Commercial Services | 4 |
Posizioni
| Director/Board Member | 112 |
| Independent Dir/Board Member | 43 |
| Corporate Officer/Principal | 17 |
| President | 15 |
| Chief Executive Officer | 14 |
Contatti più connessi
| Insiders | |
|---|---|
| Isaac Blech | 32 |
| Teresa Ressel | 32 |
| Robert Ruffolo | 24 |
| Robert Essner | 23 |
| Sigurdur Olafsson | 16 |
| Geno Germano | 15 |
| Gary Sender | 14 |
| David Zaccardelli | 10 |
| Timothy Boris | 9 |
| Natalie McDonald | 4 |
| Michelle Bradbury | 1 |
| Steven Larson | 1 |
- Borsa valori
- Insiders
- Ulrich Wiesner
- Connessioni Società